COH Share Price

Open 119.20 Change Price %
High 119.34 1 Day -1.15 -0.97
Low 116.95 1 Week -1.65 -1.39
Close 116.97 1 Month -7.72 -6.19
Volume 212126 1 Year 22.60 23.95
52 Week High 144.12
52 Week Low 89.51
COH Important Levels
Resistance 2 119.19
Resistance 1 118.27
Pivot 117.75
Support 1 115.67
Support 2 114.75
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
GPP 0.03 0.00%
PDN 0.06 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
GMR 0.01 0.00%
GMR 0.01 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
RMG 0.02 100.00%
RMG 0.02 100.00%
GME 0.03 50.00%
GME 0.03 50.00%
GME 0.03 50.00%
GME 0.03 50.00%
RHT 0.03 50.00%
RHT 0.03 50.00%
BMN 0.03 50.00%
More..
ASX Australia Top Losers Stocks
HOG 0.00 -100.00%
HOG 0.00 -100.00%
PCL 0.00 -100.00%
PCL 0.00 -100.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GTG 0.01 -50.00%
More..

Cochlear Ltd (ASX: COH)

COH Technical Analysis 4
As on 2nd Dec 2016 COH Share Price closed @ 116.97 and we RECOMMEND Sell for LONG-TERM with Stoploss of 118.34 & Strong Sell for SHORT-TERM with Stoploss of 130.08 we also expect STOCK to react on Following IMPORTANT LEVELS.
COH Target for December
1st Target up-side 125.71
2nd Target up-side 130.63
3rd Target up-side 135.55
1st Target down-side 111.69
2nd Target down-side 106.77
3rd Target down-side 101.85
COH Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.cochlear.com
COH Address
COH
1 University Avenue
Macquarie University, NSW 2109
Australia
Phone: 61 2 9428 6555
Fax: 61 2 9428 6352
COH Latest News
Interactive Technical Analysis Chart Cochlear Ltd ( COH ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cochlear Ltd
COH Business Profile
Cochlear Limited provides implantable hearing solutions. It offers the Cochlear Nucleus range of cochlear implant systems; Baha bone conduction implants for treating conductive hearing loss, mixed hearing loss, and single-sided deafness; bone anchored prosthetics, such as the Cochlear Vistafix bone-anchored facial prosthetic solution to enhance the attachment and cosmetic outcome of facial prostheses; and support services. The company provides its products directly, as well as through distributors and agents in the United States, Canada, and Latin America; Europe, the Middle East, and Africa; and Australasia and Asia. Cochlear Limited is headquartered in Macquarie University, Australia.